BioMedWire Stocks

Being Clear on Value Proposition Key to eCommerce Success

E-commerce companies have a greater chance of succeeding in an increasingly competitive and cutthroat market when they are clear on value proposition. Consumer retail surged during the coronavirus pandemic as nearly a hundred countries instituted self-isolation orders and locked down one-half the global population, forcing countless consumers to rely solely on online stores for their purchases. Convenience was the key drawing factor for most consumers and remains a big factor in the attractiveness of online commerce.

According to a Catalyst/Kantar study, 66% of consumers used convenience as their main criteria for choosing online stores while 57% valued shoppability, 52% used product assortment as their criteria and 47% cited price. However, with consumers around the world facing significant increases in the cost of living, this year’s Australian E-Commerce Report found that consumers are focusing more and more on loyalty programs and discounts and looking for price comparisons to minimize their online shopping costs.

Years of the coronavirus pandemic, an ongoing energy crisis and the reverberating effects of the Russia-Ukraine war have left the global economy battered, increasing costs almost across the board and forcing consumers to dig deeper into their pockets to survive. Online retailers can attract these cost-conscious online buyers by increasingly investing in value proposition and tailoring the online shopping experience to match current economic conditions.

IAB Australia CEO Gai Le Roy noted that while consumers are leveraging a mix of in-store and online purchases to fulfill their shopping needs, price-sensitive shoppers who want the best value for their money present new challenges for online retailers. He said that while undercutting competing companies and discounting may work in the short-term, it isn’t a feasible long-term strategy.

According to Pureprofile CEO Martin Filz, shifts in consumer behavior caused by the coronavirus pandemic have endured long after lockdown orders ended. Consumers now expect increased shopping convenience and faster deliveries, Filz commented, and they have maintained their purchase frequencies from 2022, albeit with more caution.

The report found that 62% of consumers consider loyalty programs as a key factor when choosing online retailers as they look to maximize the value of their money while improving their shopping experiences. A whopping 9 out of 10 shoppers signed up for royalty programs, and 44% of those who joined the programs had at least four cards. Furthermore, 52% of online shoppers reported paying subscription fees to retain membership in loyalty programs such as eBay Plus, Amazon Plus, Costco Membership, Woolworths Delivery Unlimited and Wesfarmers OnePass.

As more players such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) enter specialized segments of e-commerce such as healthcare e-commerce, we could see more targeted forms of value proposition fronted by companies intent on growing market share.

NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL) are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

3 days ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

5 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

5 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

6 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago